Emmanouil� Rizos

1.6k total citations
57 papers, 1.1k citations indexed

About

Emmanouil� Rizos is a scholar working on Psychiatry and Mental health, Clinical Psychology and Molecular Biology. According to data from OpenAlex, Emmanouil� Rizos has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 11 papers in Clinical Psychology and 9 papers in Molecular Biology. Recurrent topics in Emmanouil� Rizos's work include Schizophrenia research and treatment (11 papers), Tryptophan and brain disorders (7 papers) and Autism Spectrum Disorder Research (5 papers). Emmanouil� Rizos is often cited by papers focused on Schizophrenia research and treatment (11 papers), Tryptophan and brain disorders (7 papers) and Autism Spectrum Disorder Research (5 papers). Emmanouil� Rizos collaborates with scholars based in Greece, United Kingdom and Canada. Emmanouil� Rizos's co-authors include Demetrios�� Spandidos, E. Laskos, Lefteris Lykouras, Konstantinos Tsamakis, Athanasios Douzenis, Stylianos Kympouropoulos, Anastasia Kastania, Dimitrios Tsiptsios, Panayiota G. Michalopoulou and Vassilios Zoumpourlis and has published in prestigious journals such as PLoS ONE, Journal of Affective Disorders and Schizophrenia Research.

In The Last Decade

Emmanouil� Rizos

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanouil� Rizos Greece 18 354 304 243 220 141 57 1.1k
Susanne Höfels Germany 17 153 0.4× 384 1.3× 245 1.0× 375 1.7× 97 0.7× 22 1.7k
Yong Zeng China 20 286 0.8× 313 1.0× 187 0.8× 251 1.1× 43 0.3× 78 1.6k
Eleni Parlapani Greece 19 731 2.1× 111 0.4× 109 0.4× 144 0.7× 59 0.4× 44 1.3k
Ricard Navinés Spain 23 295 0.8× 107 0.4× 94 0.4× 278 1.3× 46 0.3× 57 1.5k
Henriette N. Buttenschøn Denmark 19 146 0.4× 156 0.5× 106 0.4× 132 0.6× 43 0.3× 42 1.1k
Steve R. Makkar Australia 15 153 0.4× 179 0.6× 152 0.6× 103 0.5× 24 0.2× 31 1.1k
Arthur R. Van Gool Netherlands 26 258 0.7× 57 0.2× 261 1.1× 392 1.8× 29 0.2× 71 2.1k
Apurva Prakash United States 19 418 1.2× 48 0.2× 157 0.6× 447 2.0× 55 0.4× 29 1.4k
Marek Krzystanek Poland 17 134 0.4× 133 0.4× 113 0.5× 131 0.6× 15 0.1× 110 1.0k
Dana C. Perantie United States 22 145 0.4× 141 0.5× 133 0.5× 331 1.5× 14 0.1× 40 1.6k

Countries citing papers authored by Emmanouil� Rizos

Since Specialization
Citations

This map shows the geographic impact of Emmanouil� Rizos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanouil� Rizos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanouil� Rizos more than expected).

Fields of papers citing papers by Emmanouil� Rizos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanouil� Rizos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanouil� Rizos. The network helps show where Emmanouil� Rizos may publish in the future.

Co-authorship network of co-authors of Emmanouil� Rizos

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanouil� Rizos. A scholar is included among the top collaborators of Emmanouil� Rizos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanouil� Rizos. Emmanouil� Rizos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spandidos, Demetrios��, et al.. (2025). Metabolic syndrome in patients with schizophrenia: Underlying mechanisms and therapeutic approaches (Review). Molecular Medicine Reports. 31(5). 1–16. 3 indexed citations
2.
Theleritis, Christos, Maria‐Ioanna Stefanou, Κonstantinos Τriantafyllou, et al.. (2024). Association of gut dysbiosis with first‑episode psychosis (Review). Molecular Medicine Reports. 30(1). 8 indexed citations
3.
Siafakas, Nikolaos, Cleo Anastassopoulou, Spyros Pournaras, et al.. (2024). Viruses and psychiatric disorders: We have not crossed the borderline from hypothesis to proof yet (Review). Molecular Medicine Reports. 31(3).
4.
Tsamakis, Konstantinos, et al.. (2024). Early Onset of Tardive Dyskinesia in an Antipsychotic-Naive Patient Treated With Low-Dose Cariprazine. Journal of Clinical Psychopharmacology. 44(2). 189–191.
5.
Siafakas, Nikolaos, et al.. (2023). Predominance of Recombinant Norovirus Strains in Greece, 2016–2018. Microorganisms. 11(12). 2885–2885. 1 indexed citations
6.
Hatziagelaki, Erifili, et al.. (2023). Evaluation of Quality of Life and Emotional Disturbances in Patients with Diabetic Retinopathy. European Journal of Investigation in Health Psychology and Education. 13(11). 2516–2528. 4 indexed citations
7.
Tsoporis, James N., Sahil Gupta, Ioannis Rizos, et al.. (2021). A longitudinal study of alterations of circulating DJ-1 and miR203a-3p in association to olanzapine medication in a sample of first episode patients with schizophrenia. Journal of Psychiatric Research. 146. 109–117. 20 indexed citations
8.
Tsamakis, Konstantinos, Gayan Perera, Emmanouil� Rizos, et al.. (2020). Dementia in People from Ethnic Minority Backgrounds: Disability, Functioning, and Pharmacotherapy at the Time of Diagnosis. Journal of the American Medical Directors Association. 22(2). 446–452. 18 indexed citations
9.
Nikolakakis, Nikolaos, et al.. (2020). Association between happiness and psychopathology in an elderly regional rural population in Crete. Psychiatriki. 30(4). 299–310. 8 indexed citations
10.
Parissis, John, Maria Kallergi, Emmanouil� Rizos, et al.. (2020). 18F-FDG PET/CT Brain Glucose Metabolism as a Marker of Different Types of Depression Comorbidity in Chronic Heart Failure Patients with Impaired Systolic Function. European Journal of Heart Failure. 22(11). 2138–2146. 8 indexed citations
11.
Tsoporis, James N., Nikolaos Siafakas, Erifili Hatziagelaki, et al.. (2018). A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia. CNS & Neurological Disorders - Drug Targets. 17(5). 383–388. 11 indexed citations
12.
Michopoulos, Ioannis, et al.. (2018). Association of Schizoid and Schizotypal Personality disorder with violent crimes and homicides in Greek prisons. Annals of General Psychiatry. 17(1). 35–35. 5 indexed citations
13.
Vavougios, George D., Charalabos Papageorgiou, Athanasios Douzenis, et al.. (2017). Clozapine Associated with Autoimmune Reaction, Fever and Low Level Cardiotoxicity – A Case Report. In Vivo. 31(1). 141–144. 5 indexed citations
14.
Rizos, Emmanouil�, Nikolaos Siafakas, Charalabos Papageorgiou, et al.. (2016). miRNAs and their role in the correlation between schizophrenia and cancer. Molecular Medicine Reports. 14(6). 4942–4946. 9 indexed citations
15.
Rizos, Emmanouil�, Matilda Papathanasiou, E. Laskos, et al.. (2014). A Longitudinal Study of Alterations of Hippocampal Volumes and Serum BDNF Levels in Association to Atypical Antipsychotics in a Sample of First-Episode Patients with Schizophrenia. PLoS ONE. 9(2). e87997–e87997. 31 indexed citations
16.
Douzenis, Athanasios, et al.. (2012). Factors affecting hospital stay in psychiatric patients: the role of active comorbidity. BMC Health Services Research. 12(1). 166–166. 56 indexed citations
17.
Peppa, Μelpomeni, et al.. (2012). Hypogonadism Due to Hyperprolactinemia and Subsequent First Episode of Psychosis. Gender Medicine. 9(1). 56–60. 11 indexed citations
18.
Rizos, Emmanouil�, Nikolaos Siafakas, Anna Koumarianou, et al.. (2012). miR-183 as a molecular and protective biomarker for cancer in schizophrenic subjects. Oncology Reports. 28(6). 2200–2204. 12 indexed citations
19.
Douzenis, Athanasios, et al.. (2011). The effect of ethnicity on prescribing practice and treatment outcome in inpatients suffering from schizophrenia in Greece. BMC Psychiatry. 11(1). 66–66. 3 indexed citations
20.
Rizos, Emmanouil�, Panayiota G. Michalopoulou, Nikolaos Siafakas, et al.. (2010). Association of Serum Brain-Derived Neurotrophic Factor and Duration of Untreated Psychosis in First-Episode Patients with Schizophrenia. Neuropsychobiology. 62(2). 87–90. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Höfels Breakdown of academic impact, for papers by Yong Zeng Breakdown of academic impact, for papers by Eleni Parlapani Breakdown of academic impact, for papers by Ricard Navinés Breakdown of academic impact, for papers by Henriette N. Buttenschøn Breakdown of academic impact, for papers by Steve R. Makkar Breakdown of academic impact, for papers by Arthur R. Van Gool Breakdown of academic impact, for papers by Apurva Prakash Breakdown of academic impact, for papers by Marek Krzystanek Breakdown of academic impact, for papers by Dana C. Perantie
Rankless by CCL
2026